Acorah Software Products - Accounts Production 14.6.300 false true false true No description of principal activity 23 November 2022 30 November 2023 30 November 2023 14503123 Dr Saima Khan iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14503123 2022-11-22 14503123 2023-11-30 14503123 2022-11-23 2023-11-30 14503123 frs-core:CurrentFinancialInstruments 2023-11-30 14503123 frs-bus:PrivateLimitedCompanyLtd 2022-11-23 2023-11-30 14503123 frs-bus:FilletedAccounts 2022-11-23 2023-11-30 14503123 frs-bus:Micro-entities 2022-11-23 2023-11-30 14503123 frs-bus:AuditExempt-NoAccountantsReport 2022-11-23 2023-11-30 14503123 frs-bus:Director1 2022-11-23 2023-11-30
Registered number: 14503123
Khans Med Limited
Unaudited Financial Statements
For the Period 23 November 2022 to 30 November 2023
AWR Accountants Limited
Balance Sheet
Registered number: 14503123
30 November 2023
£
Current assets 9,937
Creditors: Amounts Falling Due Within One Year (2,737 )
NET CURRENT ASSETS 7,200
TOTAL ASSETS LESS CURRENT LIABILITIES 7,200
NET ASSETS 7,200
CAPITAL AND RESERVES 7,200

Notes

1. General Information
Khans Med Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14503123 . The registered office is Lawrence House, 37 Normanton Road, Derby, DE1 2GJ.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 2
2
For the period ending 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Dr Saima Khan
Director
06/08/2024